A new article in BJU International has suggested the possibility that Prostate Health Index density (i.e., a patient’s phi score divided by his prostate volume) may be able to predict the probability of a finding of clinically significant prostate cancer on biopsy. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: clinically, health, index, insignificant, phi, prognosis, prostate, significant, test | 2 Comments »
Last September we asked whether the Oncotype DX test for risk of prostate cancer developed by Genomic Health was “ready for prime time”. In a media release issued earlier this week, the company said that it was. However, there are a number of unresolved issues that are likely to impact the uptake of this new test. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Uncategorized | Tagged: DX, Oncotype, risk, significant | 4 Comments »
The full text of a “consensus” review entitled “The contemporary concept of significant versus insignificant prostate cancer” has just been published on line in European Urology. The authors include opinion-leaders from the USA, France, Italy, Germany, Sweden and Canada. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: active surveillance, biologically, clinically, insignificant, significant | Leave a comment »
A new article in the May issue of Cancer Epidemiology, Biomarkers and Prevention appears to be a first attempt to project population-based probabilities of the occurrence of clinically significant prostate cancer among men who are diagnosed with prostate cancer but who receive no treatment. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Uncategorized | Tagged: clinical, Diagnosis, insignificant, probability, risk, significant | 5 Comments »
